$FLG

FLAGSTAR BANK, NATIONAL ASSOCIATION (FLG): Results of Operations and Financial Condition

FLAGSTAR BANK, NATIONAL ASSOCIATION (FLG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q2026earningsrelease.htm EX-99.1 Document 102 Duffy Avenue, Hicksville, NY 11801 ● Phone: (516) 683-4420 ● flagstar.com FLAGSTAR BANK REPORTS SECOND QUARTER 2026 NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.06 PER DILUTED SHARE AND ADJUSTED NET INCOME ATTRIBUT

Original reporting
Published Jul 24, 2026, 10:08 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 10:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$FLG
Bullish
medium confidence
Mentioned
$FLG
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FLGBullishMed
01

Why it matters

The filing provides fresh, trade-relevant fundamentals: profitability metrics, capital ratios, balance-sheet growth, and a new $250M share repurchase program, alongside credit-quality movements that can affect forward provision expectations.

02

Market read

Traders can update FLG valuation and risk models using the new buyback authorization, CET1 ratio, deposit and C&I loan growth, and credit-quality changes.

03

What to watch

The release highlights CRE payoff composition (39% substandard) and ACL coverage details; traders may focus on whether these trends translate into higher future credit costs even with stable NCOs.

Relevance 7/10Novelty 8/10Timing: Filed today on SEC EDGAR, covering Q2 2026 results and a new $250M repurchase authorization.

Background

This is an SEC Form 8-K filing for Flagstar Bank’s Q2 2026 results (Item 2.02) with an attached earnings release.

Company-level read

Ticker impact

$FLGBullishMedium confidence
Context

Flagstar reported Q2 2026 results, including $0.06 diluted EPS, a $250 million share repurchase program, and a 13.16% CET1 ratio.

Expected impact

Likely positive bias for the next session and into follow-through as traders price in buyback support and improving earnings power, tempered by credit metrics (non-accrual up).

Evidence & confidence

The filing is a primary earnings release with multiple decision-relevant datapoints: EPS, PPNR, CET1, deposit and C&I loan growth, and a new repurchase authorization. Credit quality is mixed (non-accrual rose), which can cap upside.

Market effects

Regional banks may see read-across on deposit cost trends (declining deposit costs) and C&I loan growth, but credit deterioration signals remain a watch item.

As a regional lender, FLG’s deposit and C&I growth could modestly influence sentiment toward similar balance-sheet positioned banks.

Limited direct global linkage; the story is primarily US regional banking fundamentals and capital management.

Counterpoint

Despite profitability, credit quality is not uniformly improving, with non-accrual loans up 5% and non-accrual growth potentially pressuring future provisions.

Key entities

  • Flagstar Bank, National Association

    Reported Q2 2026 net income, announced a $250 million share repurchase program, and disclosed CET1 and credit metrics in an 8-K earnings release.

Related articles

$FLGMed

The Bull Case For Flagstar Bank (FLG) Could Change Following New Guidance And $250 Million Buyback

Flagstar Bank (NYSE:FLG) reported Q2 2026 net income of $34 million versus a year-ago loss, issued 2026-2027 earnings guidance, and declared quarterly dividends on common and preferred stock. The bank authorized up to $250 million in share repurchases over 12 months, citing a shift from commercial real estate toward commercial and industrial lending. The article also cites 2029 revenue of $3.6 billion and earnings of $1.4 billion.

$CLSKHigh

CleanSpark Sinks 6% Even as Bitcoin Jumps 7%, MARA Holds Flat as Traders Weigh Tensions Among AI Miners

CleanSpark (CLSK) fell 6% to $11.84, while MARA Holdings (MARA) was flat at $11.14, despite Bitcoin (BTC) rising 7% to $77,740.82. Investors are reassessing the miner-to-AI-landlord pivot, with CleanSpark's mining revenue down 30% and EBITDA deeply negative. Riot Platforms (RIOT) saw initial gains from a $9.1B AI deal fade. The CoinShares Valkyrie Bitcoin Miners ETF (WGMI) dropped 3%.

$DHRMedAI 8/10

Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?

Danaher (DHR) and Intuitive Surgical (ISRG) present contrasting growth paths. Danaher benefits from improving life sciences spending, with strong bioprocessing orders and $100M revenue shifted to next year. Intuitive Surgical reports 18% YoY growth in da Vinci system placements, 70% non-GAAP gross margin, and 85% recurring revenue. Investors must decide between cyclical recovery and structural growth.

$DHRMedAI 8/10

Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?

Danaher (DHR) and Medtronic (MDT) report recovery signs. DHR benefits from life sciences demand, with bioprocessing orders growing mid-teens. MDT shows highest annual revenue growth in 10 years, with Q4 revenue at $9.8B and FY26 at $36.4B. MDT's cardiac segment grew 78% globally, driven by cardiac ablation solutions. Both companies face challenges, with MDT's growth concentrated in a few platforms and DHR's revenue delayed into next year.

$CMCLMed

Caledonia Mining (CMCL) Q2 2026 Earnings Call Transcript

Caledonia Mining (CMCL) reported Q2 2026 earnings with 18% production growth, $76M revenue, and $46M EBITDA. EPS rose 29% to $1.36. Key drivers: improved access to high-grade areas, higher gold prices, and operational improvements. Guidance revised for costs and capital expenditure, with focus on Bilboes project funding and exploration.

$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.